Welcome to The Future Labs, a podcast series talking to people building the future, today. We speak to thought leaders around the globe about the ideas and technologies that will shape our future. It’s hard to escape a week without seeing the words “artificial intelligence” plastered everywhere. Is it a revolution or just hype? In this episode we are exploring  The Future of AI in Drug Discovery and how artificial intelligence is generating new ideas for new medicines. We’re talking to Jackie Hunter, a Board Director at benevolentAI. Jackie directs the application of BenevolentAI’s technology for clinical development and gives the company the insight it needs to operate its unique business model – one which sees it not only researching, but also developing the blueprint for new drugs. Music: Beauty From Nothing by David Ibbett, performed by Sophia Subbayya Vastek